KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Profit After Tax (2016 - 2026)

Fulgent Genetics' Profit After Tax history spans 12 years, with the latest figure at -$24.8 million for Q1 2026.

  • On a quarterly basis, Profit After Tax fell 108.64% to -$24.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$74.3 million, a 77.7% decrease, with the full-year FY2025 number at -$60.5 million, down 38.09% from a year prior.
  • Profit After Tax hit -$24.8 million in Q1 2026 for Fulgent Genetics, down from -$23.4 million in the prior quarter.
  • Over the last five years, Profit After Tax for FLGT hit a ceiling of $153.6 million in Q1 2022 and a floor of -$134.3 million in Q4 2023.
  • Historically, Profit After Tax has averaged -$9.6 million across 5 years, with a median of -$13.1 million in 2023.
  • Biggest five-year swings in Profit After Tax: tumbled 862.48% in 2023 and later soared 95.39% in 2024.
  • Tracing FLGT's Profit After Tax over 5 years: stood at -$24.1 million in 2022, then plummeted by 457.96% to -$134.3 million in 2023, then soared by 95.39% to -$6.2 million in 2024, then tumbled by 278.32% to -$23.4 million in 2025, then decreased by 6.01% to -$24.8 million in 2026.
  • Business Quant data shows Profit After Tax for FLGT at -$24.8 million in Q1 2026, -$23.4 million in Q4 2025, and -$6.8 million in Q3 2025.